Opthea (ASX: OPT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Opthea Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Opthea (ASX: OPT)
Latest News
Healthcare Shares
Why the Opthea share price has skyrocketed 350% in the past year
⏸️ ASX Shares
EML Payments and these ASX mid cap shares could be destined for big things
ASX Share Market News
3 ASX biotech shares that have soared higher today
Growth Shares
3 quality mid cap ASX shares to buy with $3,000
Share Gainers
These All Ords shares have more than doubled in 12 months
⏸️ ASX Shares
10 top ASX shares to buy for strong long term returns
Growth Shares
Grow your wealth with these quality ASX healthcare shares
Growth Shares
These mid cap ASX shares could be long term market beaters
Share Gainers
Why Afterpay, Challenger, Opthea, & Wesfarmers are surging higher
Coronavirus News
Top broker tips Opthea shares as a strong buy during the coronavirus crisis
ASX Share Market News
Why this ASX healthcare share has risen over 200% in the past year
ASX Share Market News
3 ASX healthcare growth shares to add to your 2020 watchlist
Frequently Asked Questions
-
No, Opthea does not pay shareholder dividends at this time.
-
Opthea Limited listed on the ASX on 18 April 1991.
OPT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Opthea
Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company. Following the failure of its Phase 3 wet age-related macular degeneration (AMD) trials, the company discontinued that program and relaunched in June 2026 with a new focus on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung disease.
Shareholders have been asked to approve a proposed name change to Ceryvyn Therapeutics to reflect the new direction.
OPT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 08 Jul 2026 | $0.01 | $0.00 | 0.00% | 7,777,329 | $0.01 | $0.02 | $0.01 |
| 07 Jul 2026 | $0.01 | $0.00 | 0.00% | 4,723,387 | $0.02 | $0.02 | $0.01 |
| 06 Jul 2026 | $0.02 | $0.00 | 0.00% | 9,873,809 | $0.02 | $0.02 | $0.01 |
| 03 Jul 2026 | $0.01 | $0.00 | 0.00% | 3,708,050 | $0.02 | $0.02 | $0.01 |
| 02 Jul 2026 | $0.02 | $0.00 | 0.00% | 19,796,064 | $0.02 | $0.02 | $0.01 |
